Home › NDC Lookup › RxCUI directory › RxCUI 2669920

Zuranolone 25 MG Oral Capsule [Zurzuvae] — RxCUI 2669920

RxNorm drug concept · Semantic branded drug
RxCUI 2669920 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2669920
Official nameZuranolone 25 MG Oral Capsule [Zurzuvae]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZurzuvae 25 MG Oral Capsule
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)4,361 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Zuranolone 25 MG Oral Capsule [Zurzuvae] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zuranolone 25 MG Oral Capsule [Zurzuvae] RxCUI 2669920

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zuranolone 2669905
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zurzuvae 2669911
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zuranolone Oral Capsule 2669909
    • Zuranolone Oral Product 2669907
    • Zuranolone Pill 2669908
    • Zuranolone Oral Capsule [Zurzuvae] 2669915
    • Zurzuvae Oral Product 2669913
    • Zurzuvae Pill 2669914
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zuranolone 25 MG Oral Capsule SCD · 2669918
  • Zuranolone 25 MG SCDC · 2669917
  • Zuranolone Oral Capsule SCDF · 2669909
  • Zuranolone Oral Product SCDG · 2669907
  • Zuranolone Pill SCDG · 2669908

Brand-Name Concepts

  • Zuranolone 25 MG [Zurzuvae] SBDC · 2669919
  • Zuranolone Oral Capsule [Zurzuvae] SBDF · 2669915
  • Zurzuvae Oral Product SBDG · 2669913
  • Zurzuvae Pill SBDG · 2669914
  • Zurzuvae BN · 2669911

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 2669920 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64406-0029-01 1 BOTTLE in 1 CARTON (64406-029-01) / 14 CAPSULE in 1 BOTTL... ZURZUVAE Biogen MA Inc. 2023-10-31
64406-0030-01 1 BOTTLE in 1 CARTON (64406-030-01) / 14 CAPSULE in 1 BOTTL... ZURZUVAE Biogen MA Inc. 2023-10-31
64406-0030-02 1 CARTON in 1 CARTON (64406-030-02) / 1 BLISTER PACK in 1 C... ZURZUVAE Biogen MA Inc. 2023-10-31
64406-0031-01 1 BOTTLE in 1 CARTON (64406-031-01) / 14 CAPSULE in 1 BOTTL... ZURZUVAE Biogen MA Inc. 2023-10-31
Observed labelers: Biogen MA Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.